Results of HLA class II typing in 2021
Trials | Specimen | Resolution | HLA-DR | No. of labs | HLA-DQ | No. of labs | DP | No. of labs |
---|---|---|---|---|---|---|---|---|
1st | IHL-21-01 | Generic type | DRB1*04/DRB1*13 | 66 | DQB1*04/DQB1*06 | 47 | DPB1*2/DPB1*3 | 3 |
Allelic type | DRB1*04:10/DRB1*13:02 | 25 | DQB1*04:02/DQB1*06:04 | 16 | ||||
DRB1*04:10G/DRB1*13:02G | 3 | DQB1*04:02G/DQB1*06:04G | 1 | |||||
Serological equivalent | DR4/DR13 | 65 | DQ4/DQ6 | 46 | DPB1*02:01/DPB1*03:01 | 3 | ||
IHL-21-02 | Generic type | DRB1*09/DRB1*11 | 66 | DQB1*03/Blank | 47 | DPB1*3/DPB1*4 | 3 | |
Allelic type | DRB1*09:01/DRB1*11:01 | 25 | DQB1*03:01/DQB1*03:03 | 16 | DPB1*03:01/DPB1*04:02 | 3 | ||
DRB1*09:01G/DRB1*11:01G | 3 | DQB1*03:01G/DQB1*03:03G | 1 | |||||
Serological equivalent | DR9/DR11 | 65 | DQ7/DQ9 | 46 | ||||
2nd | IHL-21-03 | Generic type | DRB1*01/DRB1*10 | 67 | DQB1*05/Blank | 48 | DPB1*03/DPB1*04 | 7 |
Allelic type | DRB1*01:01/DRB1*10:01 | 28 | DQB1*05:01/DQB1*05:01 | 2 | DPB1*03:01/DPB1*04:02 | 7 | ||
DRB1*01:01G/DRB1*10:01G | 3 | DQB1*05:01/DQB1*99:99 | 18 | |||||
DQB1*05:01G/DQB1*05:01G | 1 | |||||||
Serological equivalent | DR1/DR10 | 65 | Blank | 1 | ||||
DQ5/Blank | 46 | |||||||
IHL-21-04 | Generic type | DRB1*09/DRB1*15 | 67 | DQB1*03/DQB1*06 | 48 | DPB1*05 | 1 | |
DPB1*05/Blank | 6 | |||||||
Allelic type | DRB1*09:01/DRB1*15:01 | 28 | DQB1*03:03/DQB1*06:02 | 20 | DPB1*05:01/DPB1*05:01 | 1 | ||
DRB1*09:01G/DRB1*15:01G | 3 | DQB1*03:03G/DQB1*06:02G | 1 | DPB1*05:01/DPB1*99:99 | 6 | |||
Serological equivalent | DR9/DR15 | 65 | DQ6/DQ9 | 47 |
Bold letter indicates the results which are not compliant with the intended responses.
Abbreviation: HLA, human leukocyte antigen.